News
🇺🇸 FDA Page 66Latest pharmaceutical news, drug approvals, and FDA regulatory updates
Showing 781–792 of 807 articles
FDA Approves Repatha for Pediatric Heterozygous Familial Hypercholesterolemia
FDA · cardiology · 4 min
Dr. Sarah MitchellFDA Approves Adzynma: New Treatment for Thrombotic Thrombocytopenic Purpura
FDA · Hematology · 6 min
Dr. Sarah MitchellFDA Approves First OTC Naloxone Nasal Spray for Opioid Overdose
FDA · Opioid Overdose Treatment · 5 min
Dr. Sarah MitchellFDA Grants Priority Review to Sotorasib for KRAS G12C NSCLC
FDA · non-small cell lung cancer · 4 min
Dr. Sarah MitchellFDA Approves Veozah: New Non-Hormonal Menopause Treatment
FDA · Menopause · 4 min
Dr. Sarah MitchellFDA Approves Omisirge: New Allogeneic Stem Cell Therapy for Hematologic Cancers
FDA · hematologic malignancies · 4 min
Dr. Sarah MitchellFDA Approves Updated COVID-19 Vaccines for Fall 2024
FDA · Infectious Disease · 4 min
Dr. Sarah MitchellFDA Approves Bosulif for Pediatric Chronic Myelogenous Leukemia
FDA · chronic myelogenous leukemia · 7 min
Dr. Sarah MitchellFDA Approves Ztalmy: First Therapy for CDKL5 Deficiency Seizures
FDA · neurology · 4 min
Dr. Sarah MitchellFDA Approves Opdivo Plus Chemotherapy for Gastric Cancer
FDA · gastric cancer · 4 min
Dr. Sarah MitchellFDA Approves Breyanzi: Novel CAR-T Therapy for Mantle Cell Lymphoma
FDA · mantle cell lymphoma · 4 min
Dr. Sarah MitchellFDA Approval Mirvetuximab Soravtansine: Accelerated OK for Elahere in Ovarian Cancer
FDA · Ovarian Cancer · 4 min
Dr. Sarah MitchellPopular topics
- Drug Approvals 1,128 articles
- Clinical Trials 634 articles
- Regulatory Updates 687 articles
- FDA News 502 articles
- Press Releases 443 articles
- Oncology 443 articles
- Rare Diseases 141 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways